口服转胸腺素α1基因聚球藻对小鼠T细胞亚群作用的研究

为探讨口服后转胸腺α1(Tα1)基因聚球藻对T细胞亚群的作用,将小鼠随机分为空白对照组、野生藻组、转化藻(小剂量、中剂量和大剂量)组和日达仙组,用灌服的方式,给予空白对照组20mL·kg~(-1)的生理盐水,野生藻组0.4g·kg~(-1)的野生聚球藻;转化藻小、中、大剂量组,分别0.2g·kg~(-1)、0.4g·kg~(-1)和0.6g·kg~(-1)的转Tα1基因聚球藻;日达仙组则肌注给予3.2mg·kg~(-1)的胸腺素α1(日达仙)。结果表明转Tα1基因藻口服后可显著提高CD3亚群水平,显著提高CD4亚群水平,明显提高CD4/CD8的比值。提示转Tα1基因聚球藻具有增强机体免疫功能的作用。     

鸡胸腺素β_4串联体的原核表达、纯化与活性

构建鸡Tβ4基因串联体(2Tβ4)原核表达体系,利用Ni-NTA纯化重组2Tβ4,MTT法检测其免疫活性.结果表明,构建的PET-32a(+)-2Tβ4表达载体在BL21(DE3)感受态细胞中,经0.05 mmol/LIPTG诱导表达,每克菌体平均可获6.7mg 2Tβ4.2Tβ4对淋巴细胞增殖能力与Tβ4标准品相比无显著差异,证明了所构建的鸡2Tβ4原核表达系统的有效性,为Tβ4的应用提供了基础材料.     

国产胸腺肽诱导肝癌细胞凋亡及其机制

以ＭＴＴ法检测胸腺肽对ＨｅｐＧ２的细胞毒作用,以细胞原位凋亡染色法（Ｔｕｎｅｌ法）检测胸腺肽诱导ＨｅｐＧ２细胞凋亡,并以ｗｅｓｔｅｒｎ－ｂｌｏｔ法及免疫组化法检测药物处理后ｂｃｌ－２、Ｆａｓ抗原的表达变化。结果显示在０～１５０ｕｇ／ｍＬ浓度范围内,胸腺肽对ＨｅｐＧ２无明显的细胞毒作用,当药物浓度超近１５０ｕｇ／ｍＬ以上,细胞毒作用呈上升趋势,其ＩＣ５０为３３０ｕｇ／ｍＬ,而低于１５０ｕｇ／ｍＬ的胸     

Age- and sex-related differences in the content of prothymosinα in rat tissues

Differences in the tissue content of prothymosin during the early postnatal development of male and female rats are reported. Thymus and spleen have been found to contain significantly higher amounts of prothymosin in the newborn and prepubertal animals, as compared to adults, whereas liver has been found to contain low levels of prothymosin throughout development. These findings indicate a functional association of prothymosin with the proliferating lymphoid tissues of the young rat.     

Evidence for the extranuclear localization of thymosins in thymus

A new radioimmunoassay has been developed for thymosin ₄ by generating rabbit polyclonal antibodies against the synthetic N-terminal peptide fragment 1–15 coupled to KLH. The synthetic analogue [Tyr¹²]-thymosin ₄ (1–15) was used as tracer. This radioimmunoassay, with a useful range of 10–1000 pmoles, showed cross-reactivity with the second homologous -thymosin of man and rat (thymosin ₁₀) but not of calf (thymosin ₉). This radioimmunoassay, together with an improved radioimmunoassay for the N-terminus of parathymosin , was employed for the measurement of the levels of thymosin ₄ and parathymosin in nuclear and extranuclear extracts of calf thymus. The bulk of these polypeptides was found in the extranuclear material whereas only traces were observed in the nuclear environment, which indicates the extranuclear localisation of - and -thymosins.     

Colorectal carcinoma: from tumorigenesis to treatment

Colorectal carcinoma (CRC) is a complicated and often fatal genetic disease. Fortunately, owing to rapid expansion of knowledge and technology development in oncology, much progress has been made regarding the diagnosis, understanding of the molecular genetics and malignant progression, as well as the novel regimens of CRC. In this review, we summarize the staging system, the most critical genetic and epigenetic alterations, the pleiotropic effects of MMP-7, the controversial roles of Hedgehog signaling, the intriguing involvement of thymosin β-4, and the possible contribution of the putative colon (cancer) stem cells in CRC tumorigenesis. Current treatments as well as several potentially applicable therapeutic strategies for CRC are also discussed. Received 15 September 2005; received after revision 3 November 2005; accepted 25 November 2005     

胸腺素对Ehrlich腹水癌细胞MI影响的研究

小鼠经Ehrlich腹水癌细胞感染后,随着瘤龄增长,胸腺组织逐渐萎缩,胸腺淋巴细胞与骨髓细胞有丝分裂指数降低,机体免疫力减弱,癌细胞有丝分裂指数持续增高,荷瘤小鼠注射胸腺素后,其骨髓细胞和胸腺淋巴细胞有丝分裂指数,在不同瘤龄期均有明显提高,而瘤细胞有丝分裂指数下降,说明外源性胸腺素能延缓胸腺萎缩,促进造血功能,提高机体免疫力,从而对肿瘤细胞的增长具有间接的抑制作用.     

Prothymosin alpha is not a nuclear polypeptide

Summary Using a radioimmunoassay for the NH₂-terminus of prothymosin alpha, the crossreactive material was measured in subcellular fractions of calf thymus and liver. No significant amount of crossreactive material was found in the nucleus. This provides experimental evidence against a recent hypothesis, based on structural evidence, that prothymosin alpha is a nuclear polypeptide.     

重组人干扰素α2a和胸腺肽α1融合蛋白的分子设计及其基因表达产物的鉴定

人干扰素α_2a（IFNα_2a）和胸腺肽α₁（THYα₁）联合使用效果远大于各自单独使用的效果，本文通过DNA重组技术将两者构建成一个融合蛋白药物。首先，依据IFNα_2a和THYα₁的分子结构，设计了一个连接肽，将IFNα_2a和THYα₁相连，并分别位于该融合蛋白的N端和C端。在此基础上，构建出表达载体pCJ101质粒，获得的阳性克隆307在2×YT培养基小试中，产物变性复性后经DEAE-Sepharose柱层析纯化后，在SDS-PAGE上得到相对分子质量为23000的谱带。经鉴定，融合蛋白中干扰素α_2a的比酶活性为1.34mol/s·g；检测胸腺肽α₁的活性，显示活性E玫瑰花结形成率达到20%。结果表明，融合蛋白中两种药物蛋白均较好地保持各自的生物功能，为继续研究奠定了良好基础。     

抗肺癌单链抗体融合胸腺素α1重组体的构建

以重组质粒pET39-Tα1为模板,PCR获得Tα1基因,连接到pUCm—T载体上。对质粒pET22-SeFv、pUCm—T—Tα1双酶切,回收相应片段,将Tα1连接到SeFv的C端,成功构建pET22-SeFv—Tα1重组体。